Background Lupus nephritis is the renal manifestation of systemic lupus erythematosus
(SLE)‐a disease mainly affecting young women with substantial morbidity and mortality. It is …

Background Cyclophosphamide, in combination with corticosteroids has been used to
induce remission in proliferative lupus nephritis, the most common kidney manifestation of …

Background Cyclophosphamide, in combination with corticosteroids, has been first‐line
treatment for inducing disease remission for proliferative lupus nephritis, reducing death at …

The aim is to systematically review the treatment for lupus nephritis (LN) by performing an
overview of systematic reviews and meta-analyses. Electronic databases of OVID MEDLINE …

Management of lupus nephritis has evolved considerably over the past years. Here, we
provide a comprehensive review of clinical trials that form the basis for the Kidney Disease …

Despite decades of clinical research aimed at finding the most appropriate
immunosuppressive regime, lupus nephritis (LN) remains one of the major disease …

The optimal treatment of severe lupus nephritis remains unclear. Regimens consisting of
steroid and cyclophosphamide (CYC) appear to be most effective. Infection and gonadal …

In the past years, many (randomized) trials have been performed comparing the treatment
strategies for lupus nephritis. In 2012, these data were incorporated in six different …

Objective. To compare benefits and harms of lupus nephritis (LN) induction and
maintenance treatments. Methods. We performed a systematic review and Bayesian network …

Background: Lupus nephritis (LN) is a common complication in many patients with systemic
lupus erythematosus, although renal-limited lupus nephritis has been reported as well. Early …